Drug alert number: EL (25)A/04
Date issued: 30 January 2025
Bristol Laboratories Limited is recalling the batches specified in the table as a precautionary measure due to possible microbial contamination.
Amlodipine Bristol Lab 2.5 mg Tablets, PL 17907/0435
SNOMED Code: 38095611000001108
Batch Number
Expiry Date
Pack Size
First Distributed
MF23016
July 2025
28
29/9/2023
MF23017
July 2025
28
9/10/2023
MF23018
July 2025
28
16/10/2023
MF23019
July 2025
28
26/10/2023
Active Pharmaceutical Ingredient: amlodipine besilate
Brief description of the problem
Bristol Laboratories Limited is recalling the batches specified in the table as a precautionary measure due to possible microbial contamination.
Advice for healthcare professionals
Stop supplying the above batch immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.
Full drug alert can be viewed here.
Advice for patients
No further action is required by patients as this is a Pharmacy and Wholesaler level recall. There have been no reports of patients being harmed or becoming ill from taking this medicine. Patients should continue to take medicines from this batch as prescribed by your healthcare professional.
Patients who experience adverse reactions or have any questions about the medication, should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme.
Further Information
For medical information enquiries please contact: Notifications@bristol-labs.co.uk
For stock control enquiries please contact: Notifications@bristol-labs.co.uk
The post MHRA Class 2 Medicines Recall: Amlodipine Bristol Lab 2.5mg tablets (Bristol Laboratories Limited) appeared first on Community Pharmacy England.